U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07216794) titled 'Small Trial of Alendronate Impact on the Reservoir of HIV' on Oct. 10.
Brief Summary: This clinical trial is designed to test the effects of alendronate (ALN) on people living with HIV who are already receiving antiretroviral therapy (ART). Participants are randomly assigned in a 2:1 ratio to either receive alendronate or a placebo, and neither the participants nor the researchers know who is receiving the actual treatment. The goal is to see if alendronate can reduce the size and activity of the HIV-1 reservoir in these individuals.
Study Start Date: Jan. 17, 2026
Study Type: INTERVENTIONAL
Condition:
HIV
Intervention:
DRUG: ...